In the validation cohort, analyzed by qPCR, we observed a decreasing trend in the levels of CTSL and TRPV2 in MDD patients and an increasing trend in ZNF713, which was consistent with the transcriptomic results ( Figure 6 g).
← all excerpts
Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach.
1
—
—